 |
 |
 |
 | Biomaterial
FibroGen develops and produces fully synthetic recombinant gelatins
for use in a variety of pharmaceutical and medical device applications
including vaccine and biologic stabilization, drug delivery, fluid
resuscitation, and capsule manufacturing. FibroGen's technology
allows the production of gelatins with defined molecular weights
and pI, guaranteed lot-to-lot reproducibility, and the ability to
tailor the molecule to match a specific application.
|
|
|
|
